Notice2024-20268
National Institute on Drug Abuse; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 9, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 174 (Monday, September 9, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 174 (Monday, September 9, 2024)]
[Notices]
[Pages 73102-73103]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-20268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse, Initial
Review Group; Career Development Education and Training Study
Section.
Date: October 24-25, 2024.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific
Review Officer, Division of Extramural Research, Scientific Review
Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5702,
<a href="/cdn-cgi/l/email-protection#5e2d37303a362b70353724363f35353b333f3a3f2a3637321e30373670393128"><span class="__cf_email__" data-cfemail="24574d4a404c510a4f4d5e4c454f4f4149454045504c4d48644a4d4c0a434b52">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Transformative Research on the Basic Mechanisms of
Polysubstance Use in Addiction.
Date: November 1, 2024.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Sindhu Kizhakke Madathil, Ph.D., Scientific
Review Officer, Division of Extramural Research, Scientific Review
Branch, National Institute on Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892, (301) 827-5702,
<a href="/cdn-cgi/l/email-protection#74071d1a101c015a1f1d0e1c151f1f1119151015001c1d18341a1d1c5a131b02"><span class="__cf_email__" data-cfemail="76051f18121e03581d1f0c1e171d1d131b171217021e1f1a36181f1e58111900">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Addressing HIV in Highest Risk Sexual and Gender
Minorities.
Date: November 4, 2024.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Shareen Amina Iqbal, Ph.D., Scientific Review
Officer, Division of Extramural Research, Scientific Review Branch,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 443-4577, <a href="/cdn-cgi/l/email-protection#295a41485b4c4c470740584b484569474041074e465f"><span class="__cf_email__" data-cfemail="77041f1605121219591e0615161b37191e1f59101801">[email protected]</span></a>.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Functional Validation and/or Characterization of
Genes or Variants Implicated in Substance Use Disorders and NIDA
Animal Genomics Program.
Date: November 19, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Devon Rene Oskvig, Ph.D., Scientific Review
Officer, Division of Extramural Research, Scientific Review Branch,
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue,
MSC 6021, Bethesda, MD 20892, (301) 402-6965, <a href="/cdn-cgi/l/email-protection#b0d4d5c6dfde9edfc3dbc6d9d7f0ded9d89ed7dfc6"><span class="__cf_email__" data-cfemail="85e1e0f3eaebabeaf6eef3ece2c5ebecedabe2eaf3">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
[[Page 73103]]
Dated: September 4, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-20268 Filed 9-6-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 9, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.